2014 ASH Annual Meeting: Featured Resources

In addition to presentations and abstracts being delivered by Mayo Clinic staff at the upcoming 56th ASH Annual Meeting & Exposition in San Francisco, Mayo Medical Laboratories representatives will also be available at booth #2637 in the exhibit hall to discuss:


CALR MUTATION ANALYSIS

The new CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN) should be ordered on patients with clinical suspicion of essential thrombocythemia or primary myelofibrosis

Resources:


AMYLOIDOSIS

At least 25 different proteins have been shown to cause amyloidosis and the underlying pathogenesis of each subtype of amyloidosis is unique. The treatment approach for each subtype of amyloidosis may be radically different. Mayo Clinic has developed a novel diagnostic methodology that can subtype amyloidosis in routine biopsy specimens with high accuracy.

Resources:


THROMBOTIC MICROANGIOPATHY (TMA)

Thrombotic microangiopathy is a group of disorders that is characterized by thrombocytopenia and microangiopathic hemolytic anemia (intravascular hemolysis and presence of peripheral blood schistocytes), neurological symptoms, fever, and renal dysfunction. Ischemic organ injury can occur to the brain, kidneys, heart, pancreas, liver, and lungs.

Resources:


MULTIPLE MYELOMA

The diagnosis of multiple myeloma is established by integrating the pertinent clinical, laboratory, radiologic, and pathologic data. The enumeration of plasma cells in an adequate bone marrow specimen and establishment of plasma cell clonality are the key components.

Resources:


LYMPHOMA

Lymphomas are among the most complex diseases to recognize and diagnose because they are pathologically complex, with features that overlap with reactive and inflammatory conditions and other nonhematologic malignancies. Criteria for lymphoma diagnosis rely on morphology and a variety of ancillary studies, including phenotype and genetic features.

Resources


DIAGNOSTIC IMMUNOLOGY TESTING FOR THE HEMATOLOGIST

Hematopoietic cell transplantation recalibrates every component of the hematopoietic system, in addition to resetting the clock on the immune system. Therefore, immunology testing is clinically and financially effective because it helps monitor the adequate numerical and functional recovery of the immune system.

Resources


COAGULATION DISORDER TESTING

The Mayo Clinic Special Coagulation Laboratory has been at the forefront of research, testing, and treatment of patients with bleeding and thrombosing disorders for nearly 90 years. From pioneering studies in thrombosis, hirudin, warfarin, and vitamin K physiology to cutting-edge platelet physiology, our reputation in the field continues to grow.

Resources

brentwestra

Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.